Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AXON ENTERPRISE, INC.AXON · Entity 567 | Director | July 08, 2026 | July 10, 2026 |
| TSS, Inc.TSSI · Entity 6224 | Director | January 14, 2026 | January 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AXON ENTERPRISE, INC.
Report date July 08, 2026 · Filed July 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 600 |
Reported balance
After 2026-07-08 transaction · row 1
1 source rowRow 1 · 2026-07-08 · Grant · Acquired 600 · Balance 600 F1: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on July 8, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on July 8, 2027.
TSS, Inc.
Report date January 14, 2026 · Filed January 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,784 |
Reported balance
After 2026-01-14 transaction · row 1
1 source rowRow 1 · 2026-01-14 · Grant · Acquired 3,784 · Balance 3,784 F1: These shares of common stock represent restricted stock granted pursuant to an award agreement between Mr. Mohindra and the Issuer and are subject to forfeiture. The restricted stock awarded will vest in installments as follows: (1) 1,261 shares will vest on January 14, 2027, (2) 1,261 shares will vest on January 14, 2028, and (3) 1,262 shares will vest on January 14, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock represent restricted stock granted pursuant to an award agreement between Mr. Mohindra and the Issuer and are subject to forfeiture. The restricted stock awarded will vest in installments as follows: (1) 1,261 shares will vest on January 14, 2027, (2) 1,261 shares will vest on January 14, 2028, and (3) 1,262 shares will vest on January 14, 2029.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYBEROPTICS CORP
Report date November 03, 2022 · Filed November 04, 2022
Section 16 reporting ended · disclosed 2022-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-11-03 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2022-11-03 · Disposition to issuer · Disposed 8,500 · Balance 0 F1: Disposed of pursuant to the merger agreement between the issuer and Nordson Corporation of $54.00 per share in cash on the effective date of the merger. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-11-03 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2022-11-03 · Disposition to issuer · Disposed 1,500 · Balance 0 F2: Cancelled without consideration pursuant to the merger agreement between the issuer and Nordson Corporation on the effective date of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the merger agreement between the issuer and Nordson Corporation of $54.00 per share in cash on the effective date of the merger.
F2: Cancelled without consideration pursuant to the merger agreement between the issuer and Nordson Corporation on the effective date of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2026 Filed Jul 10, 2026 20:29 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047893 · wk-form4_1783715369.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on July 8, 2027. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 20:35 UTC | TSS, Inc. TSSI · Entity 6224 | GrantCommon Stock | 3,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-26-000438 · section16.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,784 F1 · shares: These shares of common stock represent restricted stock granted pursuant to an award agreement between Mr. Mohindra and the Issuer and are subject to forfeiture. The restricted stock awarded will vest in installments as follows: (1) 1,261 shares will vest on January 14, 2027, (2) 1,261 shares will vest on January 14, 2028, and (3) 1,262 shares will vest on January 14, 2029. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:16 UTC | TSS, Inc. TSSI · Entity 6224 | GrantEmployee Stock Option · Derivative | 6,000 | $0.00 Strike: $17.79 | $0.00 |
DisclosureSEC source: 0001654954-25-013009 · section16.xml · derivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2035-11-11 F1 · derivative.exercise_date: The option becomes exercisable and may be exercised as follows: (1) 2,000 shares on November 11, 2026, (2) 2,000 shares on November 11, 2027, and (3) 2,000 shares on November 11, 2028. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 11:18 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | Disposition to issuerCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-22-000153 · primary_doc.xml · nonDerivative · entry 2 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Cancelled without consideration pursuant to the merger agreement between the issuer and Nordson Corporation on the effective date of the merger. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 11:18 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | Disposition to issuerCommon Stock | 8,500 | $54.00 | $459,000.00 |
DisclosureSEC source: 0001014108-22-000153 · primary_doc.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the merger agreement between the issuer and Nordson Corporation of $54.00 per share in cash on the effective date of the merger. Read SEC document |
| May 12, 2022 Filed May 12, 2022 19:12 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-22-000101 · primary_doc.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: These restricted shares will vest in equal increments of 500 shares on each of the dates three months, six months, and nine months after May 12, 2022 (the "2022 Transaction Date"), and 500 shares that vest on the earlier of (a) 12 months after the 2022 Transaction Date, or (b) the date of the Company's Annual Meeting of Shareholders held approximately one year after the 2022 Transaction Date. Read SEC document |
| May 13, 2021 Filed May 17, 2021 11:27 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-21-000107 · primary_doc.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · balance_after: Includes 2,000 shares of restricted stock that vest in equal increments of 500 shares on each of the dates three months, six months and nine months after May 13, 2021 (the "2021 Transaction Date"), and 500 shares that vest on the earlier of (a) 12 months after the 2021 Transaction Date, or (b) the date of the Company's Annual Meeting of Shareholders held approximately one year after the 2021 Transaction Date. Read SEC document |
| May 14, 2020 Filed May 14, 2020 17:13 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001283875-20-000005 · primary_doc.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · balance_after: Includes 2,000 shares of restricted stock that vest in equal increments of 500 shares on each of the dates three months, six months and nine months after May 14, 2020 (the "2020 Transaction Date"), and 500 shares that vest on the earlier of (a) 12 months after the 2020 Transaction Date, or (b) the date of the Company's Annual Meeting of Shareholders held approximately one year after the 2020 Transaction Date. Read SEC document |
| May 16, 2019 Filed May 20, 2019 13:09 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001283875-19-000003 · primary_doc.xml · nonDerivative · entry 1 MOHINDRA VIVEK · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · balance_after: Includes 2,000 shares of restricted stock that vest in equal increments of 500 shares on each of the dates three months, six months and nine months after May 16, 2019 (the "2019 Transaction Date"), and 500 shares that vest on the earlier of (a) 12 months after the 2019 Transaction Date, or (b) the date of the Company's Annual Meeting of Shareholders held approximately one year after the 2019 Transaction Date. Read SEC document |
| May 10, 2018 Filed May 11, 2018 12:08 UTC | CYBEROPTICS CORP CYBE · Entity 122626 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001283875-18-000006 · primary_doc.xml · nonDerivative · entry 1 Mohindra Vivak · CIK 0001448711 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · balance_after: Includes 2,000 shares of restricted stock that vest in equal increments of 500 shares on each of the dates three months, six months and nine months after May 10, 2018 (the "2018 Transaction Date"), and 500 shares that vest on the earlier of (a) 12 months after the 2018 Transaction Date, or (b) the date of the Company's Annual Meeting of Shareholders held approximately one year after the 2018 Transaction Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.